genprowebdirectory
GEN Edge
Video & Multimedia
Latest News
Login
Subscribe
News
Insights
Trends for 2020
Trends for 2021
Topics
Bioprocessing
Cancer
Drug Discovery
Genome Editing
OMICs
Translational Medicine
A-Lists
Magazine
Current Issue
Past Issues
Supplements
Subscribe
Resources
GEN Protocols
Summits
Webinars
GEN Live
eBooks
Podcasts
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Best of the Web
Best Apps
Conference Calendar
Subscribe
Create a Free Account
Get GEN Edge
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Search
Advertising
Magazine Advertising
Website Banner Advertising
eNewsletter Advertising
Webinar Sponsorship
eBook Advertising
Email Nurture Campaigns
Ad Terms and Conditions
About GEN
Contact GEN
Create a Free Account
Get GEN Edge
Log In
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Privacy Policy
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
GEN – Genetic Engineering and Biotechnology News
GEN Edge
Video & Multimedia
Latest News
Login
Subscribe
News
Aging
Exercise Started Later in Life Helps Keep Muscles Youthful; Holds Back…
Drug Discovery
Programmable Biosensor Chip Uses Single Molecules to Detect Multiomic Molecular Interactions
Cell Therapy
Human Genomic Safe Harbors Identified for Gene and Cell Therapy
Artificial Intelligence
Artificial Intelligence Could Help Detect Onset of Cardiovascular Disease
Artificial Intelligence
Machine Learning to Optimize Product Quality Measurement
Insights
All
Trends for 2020
Trends for 2021
Bioprocessing
Soft Off-Gas Sensor for CHO Cultures
Bioprocessing
Using Waddington’s Landscape to Bioprocess Stem Cells
Bioprocessing
Biomanufacturing Islands for Faster, More Efficient Cell Line Development
Artificial Intelligence
Machine Learning to Optimize Product Quality Measurement
Topics
Bioprocessing
Cancer
Drug Discovery
Genome Editing
OMICs
Translational Medicine
A-Lists
A-Lists
Seven Biopharma Trends to Watch in 2022
A-Lists
Six of the Best Reports from the Front Line of Biotechnology
A-Lists
Top 10 RNA-Based Biopharmas
Coronavirus
Top 11 Best Selling COVID-19 Vaccines and Drugs of H1 2021
A-Lists
Top 10 Spatial Biology Companies
Magazine
Current Issue
Past Issues
Supplements
Subscribe
Resources
GEN Protocols
Summits
Webinars
GEN Live
eBooks
Podcasts
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Best of the Web
Best Apps
Conference Calendar
Subscribe
Create a Free Account
Get GEN Edge
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Home
Therapeutics
Enzyme Replacement Therapy
Enzyme Replacement Therapy
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Enzyme Replacement Therapy
Rubius Therapeutics Closes $120M Financing, Plans Trials Next Year
Enzyme Replacement Therapy
Alexion to Eliminate 7% of Workforce
Enzyme Replacement Therapy
Amicus Cuts Jobs, Overhauls GSK Collab, and Acquires Callidus
Enzyme Replacement Therapy
Lonza to Manufacture Heart Failure Enzyme Replacement Therapy
Enzyme Replacement Therapy
Genzyme Gets FDA, EMA Approvals for Production Plant in Waterford, Ireland
Enzyme Replacement Therapy
Protalix, Pfizer Report FDA Approval of Plant-Derived Gaucher Disease ERT Elelyso
Enzyme Replacement Therapy
EMA Green-Lights Shire’s Manufacturing Site in Lexington, MA, for Gaucher Therapy
Enzyme Replacement Therapy
Alexion Pays $610M to Buy Enobia for Hypophosphatasia ERT Candidate
Enzyme Replacement Therapy
Oxyrane Raises $26.5M to Take Lead Enzyme Replacement Therapy Through Phase...
Enzyme Replacement Therapy
Enobia Raises $40M to Further Develop Phase II-Stage ERT for Hypophosphatasia
Enzyme Replacement Therapy
Synageva Merges with Trimeris in All-Stock Deal
Enzyme Replacement Therapy
Halozyme and Intrexon to Develop Subcutaneous Recombinant Alpha 1-Antitrypsin Replacement Therapy
Enzyme Replacement Therapy
Synageva Raises $25M Through Private Placement with Existing Investors
Enzyme Replacement Therapy
Enobia Chooses Lonza for Commercial-Scale Manufacture of Its Enzyme-Replacement Therapy
Enzyme Replacement Therapy
GSK Pays Amicus $30M Up Front for Phase III Fabry Disease...
1
2
Page 1 of 2
Scroll Up
![The new entity will be publicly traded and will focus on orphan drugs. [© Sergey Ilin - Fotolia.com]](https://www.genengnews.com/wp-content/uploads/2018/08/June13_2011_18890711_RubberManRedPiePiece_SynagevaTrimerisMerger2313447113-324x160.jpg "Synageva Merges with Trimeris in All-Stock Deal")
![Funds will be used to continue clinical development of lead LAL deficiency enzyme replacement therapy.[© Bobby4237 - Fotolia.com]](https://www.genengnews.com/wp-content/uploads/2018/08/UGENWebsitepicturesTopStoriesMarch2011March21_2011_Spreadof100dollarbills_SynagevaFinancing2005712466-324x160.jpg "Synageva Raises $25M Through Private Placement with Existing Investors")
![Pharmacological chaperone is designed to stabilize a-GAL A and restore its activity.[Sergey Ilin-Fotolia.com]](https://www.genengnews.com/wp-content/uploads/2018/08/UGENWebsitepicturesTopStoriesOct2010Oct29_18890711_RubberManRedPiePiece_GSKtakesStakeinAmicusforFabryDisease5122732422-324x160.jpg "GSK Pays Amicus $30M Up Front for Phase III Fabry Disease Drug")